The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure

MLA

Kohei Hosokawa, et al. “The Clinical Significance of PNH-Phenotype Cells Accounting for < 0.01% of Total Granulocytes Detected by the Clinical and Laboratory Standards Institute Methods in Patients with Bone Marrow Failure.” Annals of Hematology, vol. 100, Oct. 2020, pp. 1975–82. EBSCOhost, https://doi.org/10.1007/s00277-020-04314-w.

APA

Kohei Hosokawa, Ken Ishiyama, Haruhiko Ninomiya, Yuji Yonemura, Chiharu Sugimori, Mai Anh Thi Nguyen, Yukari Shirasugi, Toshiyuki Ikemoto, Yoshihiko Nakamura, Tsutomu Shichishima, Shinji Nakao, Shigeru Chiba, Yasutaka Ueda, Junichi Nishimura, Yuzuru Kanakura, Tatsuya Kawaguchi, Hideyoshi Noji, Naoshi Obara, & Kiyoshi Ando. (2020). The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure. Annals of Hematology, 100, 1975–1982. https://doi.org/10.1007/s00277-020-04314-w

Chicago

Kohei Hosokawa, Ken Ishiyama, Haruhiko Ninomiya, Yuji Yonemura, Chiharu Sugimori, Mai Anh Thi Nguyen, Yukari Shirasugi, et al. 2020. “The Clinical Significance of PNH-Phenotype Cells Accounting for < 0.01% of Total Granulocytes Detected by the Clinical and Laboratory Standards Institute Methods in Patients with Bone Marrow Failure.” Annals of Hematology 100 (October): 1975–82. doi:10.1007/s00277-020-04314-w.